Global Blood Plasma Derivatives Market to Reach $80.42 Billion by 2029, Growing at 9% CAGR

What industry-specific factors are fueling the growth of the blood plasma derivatives market?
The rise in incidences of immunodeficiency disorders is anticipated to fuel the expansion of the blood plasma derivatives market. These disorders, which can either fully or partially impair the immune system, necessitate the use of blood plasma derivatives for treatment. These derivatives, comprising over 100 different proteins and salts, are intricately involved in addressing numerous medical conditions, including immunodeficiencies. Specifically, immunoglobulins found in plasma are highly employed in managing primary immunodeficiencies. Inadequate or deficient nutrition can result in macro- and micronutrient shortages, leading to immunodeficiency. As evidence, in March 2022, the Allergy, Asthma & Clinical Immunology reported that the most prevalent condition was Common Variable Immunodeficiency (CVID), affecting 16.6% of the US population, 12.9% globally, and 13.9% universally. Consequently, the uptick in immuno deficiency disorders is propelling the blood plasma derivatives market's growth.

Get Your Blood Plasma Derivatives Market Report Here:
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

What Is the projected market size and growth rate for the blood plasma derivatives market?
The market size of blood plasma derivatives has significantly expanded in the recent past. It is predicted to increase from $51.81 billion in 2024 to $56.24 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.6%. The historic development can be credited to the escalating occurrences of hemophilia and bleeding disorders, an aging population, improved awareness and diagnoses, augmentation in surgical operations, and worldwide blood transfusion services.

The market for blood plasma derivatives is anticipated to experience substantial growth over the forthcoming years, and it is projected to escalate to $80.42 billion by 2029 with a compound annual growth rate (CAGR) of 9.4%. This anticipated growth in the forecast span can be credited to the advent of therapies for rare diseases, increased chronic illnesses, heightened healthcare spending, patient-focused treatment methods, and an expanding healthcare infrastructure. Dominant trends for this estimate period comprise improvements in fractionation procedures, patient-oriented initiatives, collaborations and partnerships, extended uses in the field of neurology, and technological breakthroughs in plasma fractionation.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What new trends are reshaping the blood plasma derivatives market and its opportunities?
Key players in the blood plasma derivatives market are turning to strategic alliances to gain market dominance. This collaboration will ensure a reliable and steady provision of essential plasma-derived medications to patients in need, helping to cater to the rising demand for immunoglobulins in France and elsewhere. For example, in January 2022, Kedrion S.p.A., an Italian biopharmaceutical company dedicated to the development, manufacturing and distribution of plasma-based therapies, entered into a partnership with LPB, a UK-based pharmaceutical business specialized in biological medical products. The Italian company will utilize LFB plasma, sourced in France by the Etablissement Français du Sang (EFS), to manufacture immunoglobulins in Hungary. This new supply of immunoglobulins, to be distributed to national hospitals per and under the surveillance of French health authorities, comes in addition to the domestic supply by LFB in France.

What major market segments define the scope and growth of the blood plasma derivatives market?
The blood plasma derivatives market covered in this report is segmented -

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types
2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:
1) By Albumin: Human Serum Albumin, Recombinant Albumin
2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII
3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX
4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin
6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

Which region dominates the blood plasma derivatives market?
North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the blood plasma derivatives industry growth?
Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What Is Covered In The Blood Plasma Derivatives Global Market Report?

• Market Size Forecast: Examine the blood plasma derivatives market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the blood plasma derivatives market for a structured understanding.
• Key Players Overview: Analyze major players in the blood plasma derivatives market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the blood plasma derivatives market.
• Segment Contributions: Evaluate how different segments drive overall growth in the blood plasma derivatives market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the blood plasma derivatives market.
• Industry Challenges: Identify potential risks and obstacles affecting the blood plasma derivatives market.
• Competitive Landscape: Review strategic developments in the blood plasma derivatives market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.